Studies are proposed which aim to gain further information that is relevant to organ transplantation. An easily quantitated in vivo model, which allows accurate assay of rejection and employs transplantation of islets of Langerhans under the kidney capsule, will be employed for experiments to ascertain the cellular basis of rejection in a variety of immunogenetic disparities and sensitization states. Similar immunogenetic and sensitization situations will be studied in vitro in an attempt to evaluate the in vivo relevance of in vitro findings; studies will be performed in both mouse and man. Limiting dilution analyses, cloning of T (and possibly other) lymphocytes and functional characterization of these cells will be applied to both in vivo and in vitro models. Special emphasis will be given to the further characterization of the antigen driven, helper-cell independent cytotoxic T lymphocyte (HITc), which was described from our laboratories in both mouse and man and which appears to combine the attributes of helper T lymphocytes and conventional cytotoxic T lymphocytes. Neonatal-tolerance will be induced under a variety of circumstances to study further the phenomenon that we refer to as """"""""composite determinant recognition"""""""" in which mice neonatally tolerized to (class I + class II) disparities demonstrate hyporeactivity in adult life to the class (I+II) disparity but are normally (or nearly so) reactive to the class I or the class II disparity presented alone. Studies of HLA restricted responses and signals required for activation, maturation and expansion of cytotoxic T lymphocytes are also proposed. The overall experimental plan is aimed at obtaining information that will allow successful organ transplantation of not only endocrine organs, such as islets, but hopefully other tissues as well.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI018326-08S1
Application #
3127852
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1980-12-01
Project End
1989-03-31
Budget Start
1988-12-01
Budget End
1989-03-31
Support Year
8
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Benfield, M R; Witson, J C; Alter, B J et al. (1993) Murine APC activation in the xenogeneic MLC. Scand J Immunol 38:130-6
Nelson, P J; Geller, R L; Podack, E et al. (1992) Molecular events in late stages of T-cell functional maturation. Scand J Immunol 35:311-20
Nelson, P J; Geller, R L; Bach, F H (1992) Gene expression in CD8 and CD4 T-cell populations following activation with the calcium ionophore A23187. Scand J Immunol 35:611-9
Geller, R L (1992) Role of cross-linking in stepwise activation of T cells. Scand J Immunol 35:327-34
Reinsmoen, N L; Bach, F H (1990) Structural model for T-cell recognition of HLA class II-associated alloepitopes. Hum Immunol 27:51-72
Wu, S K; Lu, D; Madden, M et al. (1990) Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity. Hum Immunol 27:305-22
Stock, P G; Meloche, M; Ascher, N L et al. (1989) Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells. Diabetes 38 Suppl 1:161-4
Bach, F H; Geller, R L; Nelson, P J et al. (1989) A ""minimal signal-stepwise activation"" analysis of functional maturation of T lymphocytes. Immunol Rev 111:35-57
Anderson, P M; Blazar, B R; Bach, F H et al. (1989) Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity. J Immunol 142:1383-94
Ochoa, A C; Hasz, D E; Rezonzew, R et al. (1989) Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets. Cancer Res 49:963-8

Showing the most recent 10 out of 49 publications